Trial Profile
Comparison of Everolimus- and Biolimus-Eluting Metallic Stents With (ABSORB) Everolimus-Eluting Bioresorbable Vascular Scaffold Stents in the Treatment of Coronary Lesions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Umirolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 23 Dec 2015 New trial record